EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduced DDB2 Expression Is Associated with Temozolomide Resistance in Glioblastoma Cells

Inés Grávalos-Cano iD, Teresa Morales-Ruiz iD, Rafael R Ariza iD, Teresa Roldán-Arjona iD, María Isabel Martínez-Macías

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27208941 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Inés Grávalos-Cano und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, University of Córdoba, 14014 Córdoba, Spain. Hauptthemen laut MEDLINE: Temozolomide, Glioblastoma, Drug Resistance, Neoplasm, DNA-Binding Proteins. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades, European Union, Junta de Andalucía.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) remains one of the most lethal primary brain tumours, and resistance to temozolomide (TMZ), the standard chemotherapeutic agent for GBM, represents a major obstacle to effective treatment. Although O6-methylguanine-DNA methyltransferase (MGMT) is a well-established determinant of TMZ response, MGMT status alone does not fully explain the heterogeneity of treatment outcomes, suggesting the involvement of additional DNA damage response mechanisms. Here, we investigated the contribution of different DNA repair pathways to TMZ sensitivity in a panel of GBM cell lines displaying distinct TMZ response profiles. Expression analysis of 84 DNA repair genes identified damage-specific DNA binding protein 2 (DDB2) as the only one consistently associated with TMZ sensitivity. We found that DDB2 expression was significantly reduced in TMZ-resistant cell lines and selectively induced following TMZ exposure in TMZ-sensitive cells. Proteomic profiling of representative sensitive and resistant cell models further revealed distinct responses to TMZ and identified enrichment of p53-associated DNA damage response pathways in sensitive cells, including altered expression of DDB2 and other canonical p53-regulated proteins. Importantly, siRNA-mediated depletion of DDB2 in the TMZ-sensitive A172 GBM cell line significantly reduced TMZ sensitivity. These findings provide functional evidence that DDB2 contributes to the cellular response to TMZ and extend the established roles of DDB2 in DNA repair and cancer biology to TMZ responsiveness in GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TemozolomideGlioblastomaDrug Resistance, NeoplasmDNA-Binding ProteinsAntineoplastic Agents, AlkylatingBrain NeoplasmsHumansCell Line, TumorGene Expression Regulation, NeoplasticDNA DamageDNA Repair

Stichwörter der Autor:innen

DDB2DNA damageDNA repairglioblastomatemozolomide

Substanzen

TemozolomideDNA-Binding ProteinsDDB2 protein, humanAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • Department of Genetics, University of Córdoba, 14014 Córdoba, Spain.
  • Maimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain.

ORCID-Profile: Inés Grávalos-Cano, Teresa Morales-Ruiz, Rafael R Ariza, Teresa Roldán-Arjona

Förderung

  • Ministerio de Ciencia, Innovación y Universidades
  • European Union
  • Junta de Andalucía
  • Spanish Ministry of Science, Innovation and Universities
  • European Union’s Horizon 2020 Research and Innovation Programme under the Marie Skłodowska-Curie

Zitieren

APA

Grávalos-Cano, I., Morales-Ruiz, T., Ariza, R. R., Roldán-Arjona, T., & Martínez-Macías, M. I. (2026). Reduced DDB2 Expression Is Associated with Temozolomide Resistance in Glioblastoma Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27208941

Vancouver

Grávalos-Cano I, Morales-Ruiz T, Ariza RR, Roldán-Arjona T, Martínez-Macías MI. Reduced DDB2 Expression Is Associated with Temozolomide Resistance in Glioblastoma Cells. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27208941

BibTeX
@article{GrvalosCano2026,
  author = {Grávalos-Cano, Inés and Morales-Ruiz, Teresa and Ariza, Rafael R and Roldán-Arjona, Teresa and Martínez-Macías, María Isabel},
  title = {Reduced DDB2 Expression Is Associated with Temozolomide Resistance in Glioblastoma Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27208941}
}
Kostenlos starten →